Representative Lisa C. McClain (R-Michigan) recently sold shares of Danaher Corporation (NYSE:DHR). In a filing disclosed on October 22nd, the Representative disclosed that they had sold between $1,001 and $15,000 in Danaher stock on September 25th. The trade occurred in the Representative’s “CHARLES SCHWAB BROKERAGE ACCOUNT 924” account.
Representative Lisa C. McClain also recently made the following trade(s):
- Purchased $1,001 – $15,000 in shares of FMC (NYSE:FMC) on 9/25/2025.
- Sold $1,001 – $15,000 in shares of Merit Medical Systems (NASDAQ:MMSI) on 9/25/2025.
- Purchased $1,001 – $15,000 in shares of Darden Restaurants (NYSE:DRI) on 9/25/2025.
- Purchased $1,001 – $15,000 in shares of ASML (NASDAQ:ASML) on 9/25/2025.
- Purchased $1,001 – $15,000 in shares of Kenvue (NYSE:KVUE) on 9/25/2025.
- Sold $1,001 – $15,000 in shares of Beacon Financial (NYSE:BBT) on 9/25/2025.
- Sold $1,001 – $15,000 in shares of British American Tobacco (NYSE:BTI) on 9/25/2025.
- Purchased $1,001 – $15,000 in shares of Rollins (NYSE:ROL) on 9/25/2025.
- Purchased $1,001 – $15,000 in shares of SAP (NYSE:SAP) on 9/25/2025.
- Purchased $1,001 – $15,000 in shares of MGP Ingredients (NASDAQ:MGPI) on 9/25/2025.
Danaher Stock Up 0.1%
Danaher stock opened at $223.03 on Friday. The stock has a market cap of $157.54 billion, a price-to-earnings ratio of 45.99, a PEG ratio of 3.41 and a beta of 0.77. The company has a current ratio of 1.52, a quick ratio of 1.22 and a debt-to-equity ratio of 0.33. The company’s 50-day moving average price is $202.73 and its two-hundred day moving average price is $198.36. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $258.23.
Danaher Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be paid a dividend of $0.32 per share. The ex-dividend date of this dividend is Friday, September 26th. This represents a $1.28 annualized dividend and a yield of 0.6%. Danaher’s dividend payout ratio (DPR) is presently 27.23%.
Insider Buying and Selling at Danaher
In related news, Director Teri List sold 2,778 shares of the stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the sale, the director directly owned 20,751 shares in the company, valued at approximately $4,379,706.06. This trade represents a 11.81% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 11.10% of the company’s stock.
Institutional Investors Weigh In On Danaher
A number of institutional investors have recently bought and sold shares of the business. White Pine Capital LLC boosted its holdings in shares of Danaher by 1.4% during the second quarter. White Pine Capital LLC now owns 3,494 shares of the conglomerate’s stock worth $690,000 after purchasing an additional 49 shares during the period. Boyd Watterson Asset Management LLC OH lifted its position in Danaher by 2.1% in the 2nd quarter. Boyd Watterson Asset Management LLC OH now owns 2,524 shares of the conglomerate’s stock worth $499,000 after buying an additional 51 shares in the last quarter. Hills Bank & Trust Co boosted its stake in shares of Danaher by 0.3% during the 1st quarter. Hills Bank & Trust Co now owns 18,015 shares of the conglomerate’s stock valued at $3,693,000 after buying an additional 53 shares during the period. Worth Financial Advisory Group LLC boosted its stake in shares of Danaher by 4.6% during the 2nd quarter. Worth Financial Advisory Group LLC now owns 1,195 shares of the conglomerate’s stock valued at $236,000 after buying an additional 53 shares during the period. Finally, Howard Capital Management Group LLC grew its holdings in shares of Danaher by 4.8% during the 3rd quarter. Howard Capital Management Group LLC now owns 1,159 shares of the conglomerate’s stock valued at $230,000 after acquiring an additional 53 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
Several equities analysts have commented on DHR shares. Barclays raised their target price on shares of Danaher from $225.00 to $250.00 and gave the company an “overweight” rating in a research note on Wednesday. Evercore ISI lifted their price objective on shares of Danaher from $226.00 to $245.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 7th. Scotiabank raised shares of Danaher from a “sector perform” rating to a “sector outperform” rating and set a $275.00 price objective on the stock in a research note on Friday, July 11th. Rothschild & Co Redburn reaffirmed a “neutral” rating and issued a $220.00 price objective (down previously from $245.00) on shares of Danaher in a research note on Wednesday, October 8th. Finally, Wells Fargo & Company reaffirmed a “positive” rating on shares of Danaher in a research note on Thursday. Eighteen investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $243.39.
View Our Latest Stock Analysis on Danaher
About Representative McClain
Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan’s 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027.
McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan’s 9th Congressional District. She declared candidacy for the 2026 election.
Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor’s degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Stories
- Five stocks we like better than Danaher
- How is Compound Interest Calculated?
- Rayonier-PotlatchDeltic Merger Signals Industry Upside
- How to Use Stock Screeners to Find Stocks
- Hims & Hers Short Interest Nears All-Time High, Buy The Dip?
- What is the FTSE 100 index?
- This Defense Stock Has a $57B Backlog and New AI Tailwinds
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
